
What to assess when selecting sites for a medical device trial, from patient access and procedural expertise to staffing and follow-up capacity.
Choosing the right clinical trial sites involves more than finding experienced investigators and hospitals with access to patients.
A site may have strong clinical credentials and still struggle to deliver the requirements of a particular medical device study.
Unlike many pharmaceutical trials, medical device investigations often depend on specialised equipment, procedural expertise, technical training, and consistent device use.
That makes site selection an important part of study design, not simply a step before recruitment begins.
Patient access is only part of the equation.
A site may treat a large number of patients within the target population, but that does not necessarily mean those patients will meet the study's eligibility criteria or be willing to participate.
Recruitment projections can also be affected by competing studies, referral pathways, and the practical demands of the protocol.
These factors are not always apparent from initial feasibility assessments.
Operational readiness matters just as much as clinical experience.
Medical device trials can place additional demands on investigators and site teams, particularly when procedures require specific skills or equipment.
A site that performs well in routine clinical practice may not have the resources or capacity to manage the additional responsibilities of a clinical investigation.
Several considerations can influence site suitability:
- Experience with the relevant device or procedure
- Access to the intended patient population
- Availability of trained investigators and supporting staff
- Infrastructure and equipment required by the protocol
- Capacity to manage study visits, documentation, and follow-up
These factors directly affect recruitment, protocol compliance, data quality, and study timelines.
The consequences of poor site selection often emerge later.
Recruitment may progress more slowly than anticipated.
Procedural inconsistencies may require additional training or oversight.
Sites may struggle to maintain follow-up schedules or meet documentation requirements.
Individually, these challenges may appear manageable. Together, they can affect the reliability of the evidence being generated and the overall delivery of the study.
This is why site feasibility should go beyond confirming whether a site is interested and technically capable of participating.
It should establish whether the site can realistically deliver the investigation as designed.
The strongest site selection decisions consider clinical expertise, operational capacity, patient access, and protocol requirements together.
Selecting sites early does not necessarily mean selecting the right sites.
The objective is not simply to identify where a trial can be conducted, but where it can be conducted consistently and effectively.
